Miravo Healthcare - M&A Summary, Ownership, and Business Overview

Healthcare ServicesCompany

Miravo Healthcare M&A Summary

Miravo Healthcare has acquired 3 companies of its own. It has also divested 1 asset.

Miravo Healthcare’s largest acquisition to date was in 2018, when it acquired Aralez Pharmaceuticals - VIMOVO Royalties for $110M. It’s largest disclosed sale occurred in 2014, when it sold Nuvo Research - PENNSAID to Horizon Therapeutics Public Limited Company for $45M. The Company’s most targeted sectors include life science (100%).

Miravo Healthcare Ownership

Who owns Miravo Healthcare?

Miravo Healthcare is owned by Searchlight Pharma. It was acquired on December 23, 2022.

Miravo Healthcare Business Overview

Where is Miravo Healthcare headquartered?

Miravo Healthcare is headquartered in Mississauga, Ontario.

What is Miravo Healthcare’s revenue?

Miravo Healthcare disclosed revenue of 69M CAD for 2021 and 74M CAD for 2020.

How many employees does Miravo Healthcare have?

Miravo Healthcare has 100 employees.

What sector is Miravo Healthcare in?

Miravo Healthcare is a healthcare services company.

When was Miravo Healthcare founded?

Miravo Healthcare was founded in 1983.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Miravo Healthcare

Nuvo Pharmaceuticals, Inc.

6733 Mississauga Road, Suite 610,
Mississauga, Ontario L5N 6J5
Canada,
(905) 673-6980
www.miravohealthcare.com

Miravo Healthcare is a specialty pharmaceutical company with a diverse portfolio of products and technologies. Miravo Healthcare was founded in 1983 and is based in Mississauga, Canada.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $330M $330M
Sell (0.0/yr) # 1 - - - - - 1
vol $45M $45M
  4

Most Recent M&A

Company Date Value Type
Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business 2018-09-19 110M USD Divestiture
Milton, Ontario
Aralez Pharmaceuticals, Inc. - VIMOVO Royalties 2018-08-10 110M USD Divestiture
Milton, Ontario · www.vimovo.com
Aralez Pharmaceuticals, Inc. 2018-08-10 110M USD Add-on Acquisition
Milton, Ontario · www.aralez.com
Nuvo Research - PENNSAID 2014-10-17 45M USD Divestiture
, United States
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Aralez Pharmaceuticals, Inc. 2018-08-10 Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business 2018-09-19 2
Milton, Ontario · www.aralez.com Milton, Ontario
Aralez Pharmaceuticals, Inc. 2018-08-10 Aralez Pharmaceuticals, Inc. - VIMOVO Royalties 2018-08-10 1
Milton, Ontario · www.aralez.com Milton, Ontario · www.vimovo.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 330M (100%) 1 (100%) 45M (100%)
Total 3 $330M 1 $45M

By Geo

State/Country Buy Value Sell Value
Canada 3 330M - -
  Ontario 3 330M - -
United States - - 1 45M
Domestic 3 (100%) 330M (100%) - -
Cross-border - - 1 (100%) 45M (100%)
Total 3 $330M 1 $45M

Deal Values

buy # Total
$100M to $1B 3 $330M
TOTAL $330M
Largest Aralez Pharmaceuticals, Inc. - VIMOVO Royalties
$110M (2018-08-10)
sell # Total
< $100M 1 $45M
TOTAL $45M
Largest Nuvo Research - PENNSAID
$45M (2014-10-17)

M&A Connections

Deals
Acquired from
Strategic(s)
67%
2 (67%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.